Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma

Lab / animal OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-30 ⓘ

Knocking down thymidine phosphorylase in cholangiocarcinoma cells reduced migration and angiogenesis but decreased sensitivity to 5-fluorouracil, indicating potential trade-offs in therapeutic efficacy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

AIM: To evaluate the role of thymidine phosphorylase (TP) in cholangiocarcinoma using small interfering RNA (siRNA). METHODS: A human cholangiocarcinoma-derived cell line KKU-M139, which has a naturally high level of endogenous TP, had TP expression transiently knocked down using siRNA. Cell growth, migration, in vitro angiogenesis, apoptosis, and cytotoxicity were assayed in TP knockdown and wild-type cell lines. RESULTS: TP mRNA and protein expression were decreased by 87.1% + or - 0.49% and 72.5% + or - 3.2%, respectively, compared with control cells. Inhibition of TP significantly decreased migration of KKU-M139, and suppressed migration and tube formation of human umbilical vein endothelial cells. siRNA also reduced the ability of TP to resist hypoxia-induced apoptosis, while suppression of TP reduced the sensitivity of KKU-M139 to 5-fluorouracil. CONCLUSION: Inhibition of TP may be beneficial in decreasing angiogenesis-dependent growth and migration of cholangiocarcinoma but may diminish the response to 5-fluorouracil chemotherapy.

My notes (saved in your browser only)

MeSH descriptors

Antimetabolites, Antineoplastic Bile Duct Neoplasms Carcinoma, Squamous Cell Cholangiocarcinoma Fluorouracil Thymidine Phosphorylase Antimetabolites, Antineoplastic Apoptosis Bile Duct Neoplasms Carcinoma, Squamous Cell Cell Line, Tumor Cell Movement Cell Proliferation Cholangiocarcinoma Endothelium, Vascular Endothelium, Vascular Fluorouracil Humans Neoplasm Invasiveness Neovascularization, Pathologic

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-01T09:25:17.647243+00:00
pubmed
last seen: 2026-10-08T21:07:26.396758+00:00